GAS5 and breast cancer: In breast cancer, GAS5 expression was found to be significantly down-regulated (∼2.7-fold) in cancerous tissues in breast relative to surrounding non-cancerous tissue, and this reduced expression of GAS5 was correlated with advanced Tumor-Node-Metastasis (TNM) stage and lower rates of survival in these patients [13].